Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Platinum-Sensitive Lung Small Cell Carcinoma”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)Looking for participantsNCT06663098
What this trial is testing

Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Gruppo Oncologico Italiano di Ricerca Clinica 142
Early research (Phase 1)Looking for participantsNCT05353439
What this trial is testing

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell CarcinomaPlatinum-Resistant Lung Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT01995188
What this trial is testing

Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Genentech, Inc. 41
Testing effectiveness (Phase 2)Looking for participantsNCT05914116
What this trial is testing

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
DualityBio Inc. 862
Testing effectiveness (Phase 2)Study completedNCT00116610
What this trial is testing

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Poniard Pharmaceuticals 75
Testing effectiveness (Phase 2)Study completedNCT03958045
What this trial is testing

Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma

Who this might be right for
Small Cell Lung Cancer
Zhonglin Hao 33
Testing effectiveness (Phase 2)UnknownNCT02679963
What this trial is testing

Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT04607954
What this trial is testing

Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Platinum-Resistant Lung Small Cell CarcinomaPlatinum-Sensitive Lung Small Cell CarcinomaRecurrent Extensive Stage Lung Small Cell Carcinoma+1 more
Mayo Clinic 29
Testing effectiveness (Phase 2)WithdrawnNCT05572476
What this trial is testing

Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer

Who this might be right for
Small Cell Lung CancerPlatinum-Sensitive Lung Small Cell CarcinomaExtensive-stage Small-cell Lung Cancer
Institut Bergonié
Post-approval studies (Phase 4)Looking for participantsNCT06467786
What this trial is testing

Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Tang-Du Hospital 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03896503
What this trial is testing

Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaExtrapulmonary Small Cell Neuroendocrine CarcinomaLimited Stage Lung Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 104
Testing effectiveness (Phase 2)Ended earlyNCT01904253
What this trial is testing

Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy

Who this might be right for
Small Cell Lung Cancer (SCLC)
Taiho Oncology, Inc. 18
Early research (Phase 1)Study completedNCT03898791
What this trial is testing

LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Eli Lilly and Company 48
Testing effectiveness (Phase 2)Study completedNCT01941316
What this trial is testing

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Who this might be right for
Small Cell Lung CarcinomaNon Small Cell Lung CarcinomaIrinotecan Sensitive Cancers
Cancer Research and Biostatistics Clinical Trials Consortium 78
Testing effectiveness (Phase 2)WithdrawnNCT02152059
What this trial is testing

Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy

Who this might be right for
Small Cell Lung CancerPlatinum-sensitive
AHS Cancer Control Alberta
Testing effectiveness (Phase 2)Looking for participantsNCT05284539
What this trial is testing

Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 760
Early research (Phase 1)Study completedNCT05002868
What this trial is testing

Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

Who this might be right for
Solid TumorExtensive-stage Small-cell Lung CancerLocally Advanced Breast Cancer+4 more
Rhizen Pharmaceuticals SA 23
Testing effectiveness (Phase 2)Study completedNCT00080015
What this trial is testing

Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
Ipsen 9
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 764